Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Barber, 2015, BPH6 randomized study of prostatic urethral lift (PUL) vs transurethral resection of the prostate (TURP): outcomes and patient satisfaction, Journal of Urology, 193, e19, 10.1016/j.juro.2015.02.104
Chin, 2015, BPH6 trial: a multi-centre, prospective, randomised study of the prostatic urethral lift vs. transurethral resection of the prostate (TURP), BJU International, 115, 10, 10.1111/bju.13072
Chin, 2017, Improved sleep after TURP and prostatic urethral lift (PUL): prospective, randomized study, BJU International, 119, 82, 10.1111/bju.13752
Gratzke, 2017, Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study, BJU International, 119, 767, 10.1111/bju.13714
Gratzke C Barber NJ Speakman MJ Berges R Wetterauer U Greene D Two year results of the BPH6 trial: a multi-center, prospective, randomized study of the prostatic urethral lift (PUL) vs transurethral resection of the prostate (TURP) European Urology Supplements 2016 e1076 a 10.1016/S1569-9056(16)61077-1
Gratzke C Chin P Barber N Speakman M Berges R Wetterauer U BPH6 trial two year results: the multi-national, prospective, randomised study of the prostatic urethral lift (PUL) compared to transurethral resection of the prostate (TURP) BJU International 2016 17 8 10.1111/bju.13452
NCT01533038 BPH-6: comparison of the UroLift System to TURP for benign prostatic hyperplasia clinicaltrials.gov/ct2/show/NCT01533038
Sønksen J Barber NJ Speakman MJ Berges R Wetterauer U Greene D Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study European Urology 2015 643 52 10.1016/j.eururo.2015.04.024
Sønsken, 2016, Multi-national, prospective, randomized study of the prostatic urethral lift (PUL) vs. transurethral resection of the prostate (TURP): two year results, Journal of Urology, 195, e456, 10.1016/j.juro.2016.02.1468
Barkin, 2017, Prospective, randomized, controlled study of five-year results on prostatic urethral lift (PUL), Canadian Urological Association Journal, 11, S326, 10.5489/cuaj.4896
McVary KT Gange SN Shore ND Bolton DM Cowan BE Brown BT Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift Journal of Sexual Medicine 2014 279 87 10.1111/jsm.12333
NCT01294150 The safety and effectiveness of UroLift: LIFT Pivotal Study (LIFT) clinicaltrials.gov/ct2/show/NCT01294150
Rane A McNicholas T Woo H Roehrborn C 4 year results of the randomized, controlled, blinded, multi-center study for the prostatic urethral lift: the L.I.F.T. study Journal of Endourology 2017 A105 6
Rashid, 2014, Multi-center prospective study of the prostatic urethral lift with two year durability, BJU International, 113, 14, 10.1111/bju.12618
Rashid, 2017, Prospective, randomised study of prostatic urethral lift: five year results, BJU International, 119, 45, 10.1111/jsm.12333
Rashid P Chin P Bolton D Rukstalis D Giddens J Gange S Prospective, randomised study of prostatic urethral lift (PUL) with three year results BJU international 2015 10 1 10.1111/bju.13072
Roehrborn C Gange S Shore N Giddens J Bolton D Cowan B 5 year prospective, randomized, controlled study results on the minimally invasive prostatic urethral lift (PUL) Journal of Urology 2017 e511
Roehrborn, 2016, Four year results from the largest, prospective, randomized study of prostatic urethral lift (PUL), European Urology Supplements, 15, e1077, 10.1016/S1569-9056(16)61078-3
Roehrborn, 2017, Long term (5 year) results from the largest, prospective, randomized, controlled study of the minimally invasive prostatic urethral lift (PUL), European Urology Supplements, 16, e334, 10.1016/S1569-9056(17)30258-0
Roehrborn C Gange S Shore N Giddens J Bolton D Cowan B Prospective, randomised, blinded study of prostatic urethral lift (PUL): four year results BJU International 2017 19 20 10.1111/bju.13452
Roehrborn, 2016, Prospective, randomized, blinded study of prostatic urethral lift (PUL): four year results, Journal of Urology, 195, e456, 10.1016/j.juro.2016.02.1469
Roehrborn C Gange S Shore N Giddens J Bolton D Cowan B Three year durability of the prostatic urethral lift for BPH: Results of a prospective, multi-center, randomized study Journal of Urology 2015 e92 10.1016/j.juro.2015.02.300
Roehrborn, 2017, Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study, Canadian Journal of Urology, 24, 8802
Roehrborn CG Gange SN Shore ND Giddens JL Bolton DM Cowan BE Durability of the prostatic urethral lift: 2-year results of the L.I.F.T. study Urology Practice 2015 26 32 10.1016/j.urpr.2014.08.001
Roehrborn CG Gange SN Shore ND Giddens JL Bolton DM Cowan BE The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. study Journal of Urology 2013 2161 7 10.1016/j.juro.2013.05.116
Roehrborn CG Rukstalis DB Barkin J Gange SN Shore ND Giddens JL Three year results of the prostatic urethral L.I.F.T. study Canadian Journal of Urology 2015 7772 82
Roehrborn CG Rukstalis DB Giddens JL Gange SN Shore ND Bolton DM Two year durability of the prostatic urethral lift: multi-center prospective study Journal of Urology 2014 e792 3 10.1016/j.juro.2014.02.2167
Woo, 2014, Prostatic urethral lift treats LUTS while preserving sexual function: results of a randomized controlled trial, BJU International, 113, 16, 10.1111/bju.12618
Gratzke, 2018, Predictors of response to the prostatic urethral lift (PUL) treatment, European Urology, Supplements, 17, e1041, 10.1016/S1569-9056(18)31556-2
NCT03043222 Innovative minimally invasive options in treatment of urinary problems related to prostate enlargement (BPH) in men clinicaltrials.gov/show/NCT03043222
Pereira K Ford-Glanton S Johar R Xu P Pham K Gadani S Prostatic artery embolization (PAE) and prostatic urethral lift (PUL) procedures for symptomatic benign prostatic enlargement (BPH): a retrospective, single-center comparison of outcomes Journal of Vascular and Interventional Radiology 2018 S6 10.1016/j.jvir.2018.01.010
Agarwal, 2014, What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women, European Urology, 65, 1211, 10.1016/j.eururo.2014.01.019
Barry, 1992, The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association, Journal of Urology, 148, 1549-57; discus
Barry, 1995, Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?, Journal of Urology, 154, 1770, 10.1016/S0022-5347(01)66780-6
Barry, 1997, The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists, Journal of Urology, 157, 10-4; discussio, 10.1016/S0022-5347(01)65267-4
Bhojani, 2014, Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program, Journal of Endourology, 28, 831, 10.1089/end.2013.0805
Brasure, 2016, AHRQ comparative effectiveness reviews, Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: a Review
Chapple C Castro-Diaz D Chuang YC Lee KS Liao L Liu SP Prevalence of lower urinary tract symptoms in China, Taiwan, and South Korea: results from a cross-sectional, population-based study Advances in Therapy 2017 1953 65
Chin, 2012, Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia, Urology, 79, 5, 10.1016/j.urology.2011.10.021
Cornu, 2010, A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines, European Urology, 58, 450, 10.1016/j.eururo.2010.05.045
Veritas Health Innovation Covidence 2013
Crawford, 2006, Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo, Journal of Urology, 175, 1422-6; discuss, 10.1016/S0022-5347(05)00708-1
Deeks JJ Higgins JP Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Annals of Surgery, 240, 205, 10.1097/01.sla.0000133083.54934.ae
Dunphy, 2015, Relationship between depression and lower urinary tract symptoms secondary to benign prostatic hyperplasia, Reviews in Urology, 17, 51
European Association of Urology Treatment of non-neurogenic male LUTS uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/
Egan, 2016, The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates, Urologic Clinics of North America, 43, 289, 10.1016/j.ucl.2016.04.001
Clarivate Analytics EndNote 2016
McMaster University (developed by Evidence Prime) GRADEpro GDT 2015
Guyatt, 2008, GRADE: what is "quality of evidence" and why is it important to clinicians?, BMJ (Clinical Research Ed), 336, 995, 10.1136/bmj.39490.551019.BE
Guyatt, 2011, GRADE guidelines 6. Rating the quality of evidence - imprecision, Journal of Clinical Epidemiology, 64, 1283, 10.1016/j.jclinepi.2011.01.012
Guyatt, 2011, GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables, Journal of Clinical Epidemiology, 64, 383, 10.1016/j.jclinepi.2010.04.026
Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Statistics in Medicine, 21, 1539, 10.1002/sim.1186
Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ (Clinical Research Ed), 327, 557, 10.1136/bmj.327.7414.557
Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Higgins JP Deeks JJ Altman DG Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Homma, 1997, Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score, International Journal of Urology, 4, 40, 10.1111/j.1442-2042.1997.tb00138.x
Jaeschke, 1989, Measurement of health status. Ascertaining the minimal clinically important difference, Controlled Clinical Trials, 10, 407, 10.1016/0197-2456(89)90005-6
Johnston, 2013, Patient-reported outcomes in meta-analyses - Part 1: assessing risk of bias and combining outcomes, Health and Quality of Life Outcomes, 11, 109, 10.1186/1477-7525-11-109
Jones, 2016, Medium-term outcomes of UroLift (minimum 12 months follow-up): evidence from a systematic review, Urology, 97, 20, 10.1016/j.urology.2016.05.003
Jung, 2017, Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012832
Kozminski, 2015, Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH), BJU International, 115, 308, 10.1111/bju.12802
Lee, 2017, The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis, Scientific Reports, 7, 7984, 10.1038/s41598-017-06628-8
Leissner, 1979, The weight of the human prostate, Scandinavian Journal of Urology, 13, 137, 10.3109/00365597909181168
Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Medicine, 6, e1000100, 10.1371/journal.pmed.1000100
Magistro, 2018, Mini-review: what is new in UroLift?, European Urology Focus, 4, 36, 10.1016/j.euf.2018.01.013
Martin, 2014, Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men, Journal of Urology, 191, 130, 10.1016/j.juro.2013.06.018
McNicholas, 2016, Benign prostatic hyperplasia and new treatment options - a critical appraisal of the UroLift system, Medical Devices, 9, 115, 10.2147/MDER.S60780
McVary, 2011, Update on AUA guideline on the management of benign prostatic hyperplasia, Journal of Urology, 185, 1793, 10.1016/j.juro.2011.01.074
National Institute for Health and Care Excellence UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia www.nice.org.uk/guidance/mtg26
Nickel, 2015, Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia - integrated data from 1,499 study participants, BJU International, 115, 815, 10.1111/bju.12926
Pariser, 2015, National trends of simple prostatectomy for benign prostatic hyperplasia with an analysis of risk factors for adverse perioperative outcomes, Urology, 86, 721, 10.1016/j.urology.2015.06.048
Perera, 2015, Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis, European Urology, 67, 704, 10.1016/j.eururo.2014.10.031
Reich, 2008, Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients, Journal of Urology, 180, 246, 10.1016/j.juro.2008.03.058
Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
Roehrborn C McConnell J Barry M Benaim E Bruskewitz R Blute ML American Urological Association guideline: management of benign prostatic hyperplasia (BPH) www.auanet.org/documents/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdf
Roehrborn, 2008, Pathology of benign prostatic hyperplasia, International Journal of Impotence Research, 20 Suppl 3, S11, 10.1038/ijir.2008.55
Roehrborn, 2008, Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations, Review in Urology, 10, 14
Rosen, 1997, The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0
Rosen, 2007, Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction, Urology, 69, 805, 10.1016/j.urology.2007.02.036
Sanchez-Gomez, 2015, Efficacy and safety of the UroLift ® system for the treatment of benign prostate hyperplasia symptoms: systematic review, Actas Urológicas Españolas, 39, 311, 10.1016/j.acuroe.2015.04.002
Schünemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Schünemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Schünemann, 2013, Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions, Research Synthesis Methods, 4, 49, 10.1002/jrsm.1078
Spaliviero, 2010, Does Greenlight HPS (™) laser photoselective vaporization prostatectomy affect sexual function?, Journal of Endourology, 24, 2051, 10.1089/end.2010.0296
Sterne, 2016, ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ, 355, i4919, 10.1136/bmj.i4919
Strope, 2015, Use of medical therapy and success of laser surgery and transurethral resection of the prostate for benign prostatic hyperplasia, Urology, 86, 1115, 10.1016/j.urology.2015.07.019
Walsh, 2017, State of the art: advanced techniques for prostatic urethral lift for the relief of prostate obstruction under local anesthesia, Canadian Journal of Urology, 24, 8859
World Health Organization Proposed working definition of an older person in Africa for the MDS project www.who.int/healthinfo/survey/ageingdefnolder/en
Woo, 2012, Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia, Journal of Sexual Medicine, 9, 568, 10.1111/j.1743-6109.2011.02568.x